Name Net reduced
positions
Reduced positions Increased positions Return since
30 Jun ‘22
701
1 1 0 32.9%
702
1 2 1 55.7%
703
1 21 20 2.13%
OSG
704
Octave Specialty Group
OSG
$245M
1 52 51 52.1%
705
1 1 0 54.8%
706
1 7 6 32.4%
707
1 5 4 94.6%
708
1 4 3 64%
709
1 6 5 97.7%
710
1 2 1 2.47%
HBIO icon
711
Harvard Bioscience
HBIO
$24.6M
1 30 29 84.7%
712
1 1 0 26.2%
713
1 15 14 67.2%
714
1 8 7 80%
715
1 2 1 32.4%
716
1 15 14 78.7%
717
1 3 2 99.7%
718
1 9 8 60.9%
719
1 1 0 99.9%
720
1 9 8 57.9%
721
1 1 0 41.6%
722
1 1 0 100%
723
1 3 2 13.9%
724
1 4 3 4.33%
725
1 4 3 64.9%